Targeting Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML): Moving beyond Prognostication

Measurable residual disease (MRD) assessment in acute myeloid leukemia (AML) has an established role in disease prognostication, particularly in guiding decisions for hematopoietic cell transplantation in first remission. Serial MRD assessment is now routinely recommended in the evaluation of treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiong, Ing S., Loo, Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003715/
https://www.ncbi.nlm.nih.gov/pubmed/36902217
http://dx.doi.org/10.3390/ijms24054790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003715/
https://www.ncbi.nlm.nih.gov/pubmed/36902217
http://dx.doi.org/10.3390/ijms24054790

Ejemplares similares